Evidence map›Paper›PMID 40518047›Full record

ArticleIndian pacing and electrophysiology journal

Natural courses of atrial fibrillation following cryptogenic stroke: A systematic review and meta-analysis.

Patavee Pajareya, Somkiat Phutinart, Noppachai Siranart, Suwit Paksin, Priabprat Jansem, Prakit Anukoolwittaya, Piyoros Lertsanguansinchai, Narut Prasitlumkum, Ronpichai Chokesuwattanaskul, Nithi Tokavanich

Abstract read
In one paragraph

Article in Indian pacing and electrophysiology journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Unveiling the silent enemy: Revisiting post-stroke AF detection.Indian pacing and electrophysiology journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patavee PajareyaDivision of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Somkiat PhutinartDivision of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Noppachai SiranartDivision of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Suwit PaksinDivision of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Priabprat JansemFaculty of Medicine, Prince of Songkhla University, Songkhla, Thailand.
Prakit AnukoolwittayaDivision of Neurology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Piyoros LertsanguansinchaiDivision of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Narut PrasitlumkumDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.
Ronpichai ChokesuwattanaskulDivision of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Nithi TokavanichDivision of Cardiovascular Medicine, University of Michigan Health, Ann Arbor, MI, United States. Electronic address: tokavanichn@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCryptogenic stroke (CS) presents challenges in management and increases risk of stroke recurrence. The clinical relevance of atrial fibrillation detected after stroke (AFDAS) remains equivocal.

methodsOur study was conducted in a meta-analysis design, including all observational studies and utilizing random-effects model. The objectives were to explore the association between predictors and AFDAS incidence, and clinical differences between AF and non-AF patients following CS.

resultsThis meta-analysis included 59 studies with 18,683 patients with CS. AFDAS incidence was 20.8 %. In univariable analysis, significant predictors of AFDAS were age >75 years (OR 6.94, 95 % CI: 3.12-15.43, I

conclusionOur study highlighted the potential link between certain comorbidities and demonstrated the delay in AF detection following CS. The significant parameters identified should be considered as new recommendations to the guideline for extended cardiac monitoring in CS patients. It is time to change the level of surveillance in this population.

Indexed as

Atrial fibrillationBiomarkersEchocardiographyElectrocardiographyStroke

Identifiers

PMID40518047
PMCPMC12461730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.